Miloslav Marel

412 total citations
14 papers, 282 citations indexed

About

Miloslav Marel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Miloslav Marel has authored 14 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Miloslav Marel's work include Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Miloslav Marel is often cited by papers focused on Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Miloslav Marel collaborates with scholars based in Czechia, United States and Romania. Miloslav Marel's co-authors include Richard W. Light, E Švandová, J Schützner, P Pafko, Jan Betka, Roman Kodet, Martin Svatoň, Milan Maçek, Jiří Blažek and Vı́tězslav Kolek and has published in prestigious journals such as CHEST Journal, Anesthesiology and Respiration.

In The Last Decade

Miloslav Marel

11 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miloslav Marel Czechia 4 268 69 63 21 18 14 282
Aleš Rozman Slovenia 11 262 1.0× 62 0.9× 40 0.6× 21 1.0× 5 0.3× 31 323
Ángel Salvatierra Velázquez Spain 6 235 0.9× 63 0.9× 83 1.3× 4 0.2× 31 1.7× 22 281
Enrique Cases Spain 10 150 0.6× 29 0.4× 53 0.8× 4 0.2× 7 0.4× 16 198
Domingo Chimondeguy Argentina 5 189 0.7× 57 0.8× 40 0.6× 5 0.2× 3 0.2× 14 223
Elena Paracchini Italy 9 174 0.6× 71 1.0× 15 0.2× 11 0.5× 6 0.3× 18 223
Meng‐Heng Hsieh Taiwan 11 175 0.7× 42 0.6× 9 0.1× 18 0.9× 8 0.4× 23 255
Vasileios Skouras Greece 7 150 0.6× 90 1.3× 73 1.2× 1 0.0× 29 1.6× 21 223
Nader Chebib France 8 95 0.4× 26 0.4× 13 0.2× 3 0.1× 26 1.4× 17 163
Quentin Maestraggi France 6 27 0.1× 48 0.7× 26 0.4× 6 0.3× 7 0.4× 11 138
Esther San‐José Spain 9 136 0.5× 43 0.6× 32 0.5× 27 1.5× 11 193

Countries citing papers authored by Miloslav Marel

Since Specialization
Citations

This map shows the geographic impact of Miloslav Marel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloslav Marel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloslav Marel more than expected).

Fields of papers citing papers by Miloslav Marel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miloslav Marel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloslav Marel. The network helps show where Miloslav Marel may publish in the future.

Co-authorship network of co-authors of Miloslav Marel

This figure shows the co-authorship network connecting the top 25 collaborators of Miloslav Marel. A scholar is included among the top collaborators of Miloslav Marel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloslav Marel. Miloslav Marel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Marel, Miloslav, Jana Skřičková, Libor Havel, et al.. (2022). Worse Prognosis in the Symptomatic Patients With Lung Cancer – Czech Multicentric Study. Cancer Diagnosis & Prognosis. 2(2). 167–172.
2.
Svatoň, Martin, et al.. (2022). Laboratory Parameters Associated With Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer. Anticancer Research. 42(3). 1563–1569. 2 indexed citations
3.
Svatoň, Martin, et al.. (2022). Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer. Translational Cancer Research. 11(9). 3017–3023.
4.
Marel, Miloslav, et al.. (2020). Biopsy of lung lesions under CT control. Biomedical Papers. 165(4). 390–394. 3 indexed citations
5.
Suchánek, Vojtěch, et al.. (2017). Vanishing Lung Syndrome in a Cystic Fibrosis Patient. Archivos de Bronconeumología. 53(8). 451–451. 1 indexed citations
6.
Marel, Miloslav, et al.. (2017). [The differential diagnosis of pleural effusions].. PubMed. 62(7-8). 598–604. 1 indexed citations
7.
Marel, Miloslav, et al.. (2016). Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up. Biomedical Papers. 160(2). 276–279. 2 indexed citations
8.
Kolek, Vı́tězslav, et al.. (2016). Biodegradable stents: Our results in 23 patients with tracheal narrowing. PA3831–PA3831. 1 indexed citations
9.
Marel, Miloslav, et al.. (2015). Lung cancer, pulmonary emphysema and pleural effusion: An autopsy study. Biomedical Papers. 159(4). 642–647. 1 indexed citations
10.
Skřičková, Jana, Karel Hejduk, Miloš Pešek, et al.. (2014). Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients. 44. 2721.
11.
Marel, Miloslav, et al.. (2005). Management of Benign Stenoses of the Large Airways in the University Hospital in Prague, Czech Republic, in 1998–2003. Respiration. 72(6). 622–628. 23 indexed citations
12.
Marel, Miloslav, et al.. (2001). Jet Ventilation for Fiberoptic Bronchoscopy. Anesthesiology. 94(5). 930–932. 5 indexed citations
13.
Marel, Miloslav, et al.. (1995). Diagnosis of Pleural Effusions. CHEST Journal. 107(6). 1598–1603. 106 indexed citations
14.
Marel, Miloslav, et al.. (1993). The Incidence of Pleural Effusion in a Well-Defined Region. CHEST Journal. 104(5). 1486–1489. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026